483
Lonza Biologics, Inc.FDA 483 - Lonza Biologics, Inc. - July 21, 2023
Record Details
An FDA inspection of Lonza Biologics, Inc. in Portsmouth, NH, revealed a significant issue regarding the qualification of critical manufacturing equipment. The firm failed to adequately qualify a Grade A bottle filler, specifically in demonstrating unidirectional airflow during both static and dynamic operations. This deficiency raises concerns about the control of the aseptic processing environment for drug substance manufacturing.
Open in Dashboard
ID · 868ee773-89d9-4285-aa55-f226970279fa